FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma
Head & Neck · 15.11.2026
DOI: 10.1002/hed.70545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 15.11.2026. Verfasst von Shuang Teng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China. Die Arbeit nennt 20 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Wuyuan Research Fund of the Fifth Affiliated Hospital of Harbin Medical University.
Abstract (Originalsprache)
Background
Fibrinogen‐like protein 1 (FGL1) is involved in tumor progression and immune regulation, but its role in laryngeal squamous cell carcinoma (LSCC) is unclear.
Methods
Plasma FGL1 levels were measured in 120 LSCC patients and 50 controls using ELISA. Tissue expression was analyzed via TCGA‐HNSC. Functional assays evaluated proliferation, migration, invasion, apoptosis, and cisplatin sensitivity. Prognostic value was assessed using survival and regression analyses.
Results
FGL1 was significantly elevated in LSCC plasma and tumor tissues. Functional studies showed that FGL1 promotes proliferation, migration, invasion, and EMT while inhibiting apoptosis and enhancing cisplatin resistance. Mechanistically, FGL1 knockdown increased Cleaved Caspase‐3 and decreased Bcl‐2 expression. High FGL1 levels were associated with poorer overall survival and independently predicted prognosis.
Conclusion
FGL1 promotes LSCC progression and chemoresistance, highlighting its potential as a circulating biomarker and therapeutic target.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Otolaryngology, Head and Neck Surgery, Fifth Affiliated Hospital, Harbin Medical University, Daqing, Heilongjiang, China.
ORCID-Profile: Shuang Teng, Shuo Liu, Rui Zhao, Ya-Nan Sun
Förderung
- National Natural Science Foundation of China
- Wuyuan Research Fund of the Fifth Affiliated Hospital of Harbin Medical University
Zitieren
APA
Teng, S., Jin, M., Yan, B. R., Qu, L. M., Xu, Z. N., Liu, S., Li, Q. Y., Zhang, F. S., Hao, Q., Guo, S., Zhao, R., & Sun, Y. N. (2026). FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.70545
Vancouver
Teng S, Jin M, Yan BR, Qu LM, Xu ZN, Liu S, et al. FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma. Head & Neck. 2026. doi:10.1002/hed.70545
BibTeX
@article{Teng2026,
author = {Teng, Shuang and Jin, Meng and Yan, Bing-Rui and Qu, Ling-Mei and Xu, Zhao-Nan and Liu, Shuo and Li, Qiu-Ying and Zhang, Feng-Shuo and Hao, Qing and Guo, Shuang and Zhao, Rui and Sun, Ya-Nan},
title = {FGL1 Drives Epithelial–Mesenchymal Transition and Cisplatin Resistance in Laryngeal Squamous Cell Carcinoma},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70545}
}
EUVIMED